Study Finds Lower Substance Use Disorder Diagnoses in GLP-1 Drug Users
In Brief
A large study found people on GLP-1 drugs like Ozempic had fewer substance use disorder diagnoses.
Key Facts
- A large study examined people taking GLP-1 drugs such as Ozempic for diabetes.
- Study participants were less likely to be diagnosed with substance use disorder.
- GLP-1 drugs are already used for diabetes and weight loss treatment.
What Happened
According to NPR, a large study found that individuals taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.
Why It Matters
GLP-1 drugs are widely used for diabetes and weight loss. The study's findings may prompt further research into their potential effects on substance use disorder diagnoses. Based on a single source report
What's Next
Researchers may investigate the mechanisms behind the observed association and consider clinical trials to explore GLP-1 drugs' potential role in addiction treatment.
Sources
- NPR News — GLP-1s have transformed weight loss and diabetes. Is addiction next?(1d ago)
